Skip to content

Profound Medical PROF EPS (Diluted)

EPS (Diluted) at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
$2.28+18.7%
Bioventus logo
BioventusBVS
$0.04+200%

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K
Free cash flow-$9.6M

Valuation

See full
Market cap$241.65M+30.7%
Enterprise value$198.81M+28.7%
P/S12.8×-2.8×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's EPS (diluted)?
Profound Medical (PROF) reported EPS (diluted) of $0.19 in Q1 2026.
How has Profound Medical's EPS (diluted) changed year-over-year?
Profound Medical's EPS (diluted) decreased by 47.2% year-over-year, from $0.36 to $0.19.
What is the long-term trend for Profound Medical's EPS (diluted)?
Over 2 years (2023 to 2025), Profound Medical's EPS (diluted) has grown at a 2.6% compound annual growth rate (CAGR), from $1.34 to $1.41.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.